IQ EQ FUND MANAGEMENT IRELAND Ltd Has $1.61 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

IQ EQ FUND MANAGEMENT IRELAND Ltd reduced its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 25.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,950 shares of the company's stock after selling 1,381 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd's holdings in HCA Healthcare were worth $1,605,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter worth approximately $27,000. Unique Wealth Strategies LLC acquired a new stake in shares of HCA Healthcare during the 2nd quarter valued at $28,000. Bangor Savings Bank grew its holdings in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company's stock worth $27,000 after acquiring an additional 45 shares during the last quarter. GPS Wealth Strategies Group LLC lifted its holdings in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock valued at $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare during the 2nd quarter worth about $33,000. Institutional investors own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the business's stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the business's stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares of the company's stock, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 17,202 shares of company stock worth $6,407,273 over the last three months. Company insiders own 1.60% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on HCA shares. Barclays boosted their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an "overweight" rating in a report on Wednesday, July 24th. UBS Group upped their price target on HCA Healthcare from $405.00 to $438.00 and gave the company a "buy" rating in a research report on Wednesday, August 14th. Morgan Stanley assumed coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an "equal weight" rating and a $427.00 target price on the stock. Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 30th. Finally, KeyCorp assumed coverage on HCA Healthcare in a research report on Friday, October 11th. They set an "overweight" rating and a $475.00 price objective for the company. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have given a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $365.65.

HCA Healthcare Stock Performance

HCA Healthcare stock traded up $7.82 during mid-day trading on Friday, reaching $414.30. The company had a trading volume of 616,376 shares, compared to its average volume of 1,137,631. The company has a 50 day moving average of $391.08 and a 200-day moving average of $349.57. The firm has a market cap of $108.51 billion, a price-to-earnings ratio of 20.26, a PEG ratio of 1.44 and a beta of 1.67. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts' consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company's quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the company earned $4.29 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were given a dividend of $0.66 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.64%. HCA Healthcare's dividend payout ratio (DPR) is presently 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.